STOCKSCREENR
Log In

TMCI

NASDAQ

Treace Medical Concepts, Inc.

$1.46+0.04(+2.82%)Mkt Cap: $94.30M

Key Stats

Market Cap

$94.30M

P/E Ratio

-1.57

EPS

$-0.93

Dividend Yield

0.00%

52-Week Range

$1.31 — $8.87

Volume

386.89K

Avg Volume

833.64K

Beta

0.77

Valuation

P/E (TTM)

-1.57

Forward P/E

—

PEG Ratio

0.09

P/S (TTM)

0.42

P/B (TTM)

1.02

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.62%

ROA (TTM)

-0.31%

ROIC

—

Gross Margin

0.80%

Operating Margin

-0.25%

Net Margin

—

Debt/Equity

0.16

Current Ratio

4.31

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.40%

EPS Growth (5Y)

-0.91%

Sales Growth (3Y)

+0.31%

Sales Growth (5Y)

+0.41%

EPS Est (This Year)

$-0.85

EPS Est (Next Year)

$-0.82

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.76

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

63.72M

Float

47.46M

Free Float %

74.48%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2021-04-23

Employees

477

CEO

John T. Treace

Index Membership

—

Website

https://www.treace.com

Treace Medical Concepts, Inc. (TMCI) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $94.30M, a P/E ratio of -1.57, TMCI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare TMCI against other stocks using dozens of fundamental and technical filters.

Similar Stocks

PRN.TO

Profound Medical Corp.

$8.02

+3.08%

$242.68M

LAB

Standard BioTools Inc.

$0.98

+3.01%

$378.30M

VMD

Viemed Healthcare, Inc.

$9.69

-0.92%

$375.83M

AVR

Anteris Technologies Global Corp.

$5.97

-4.78%

$219.63M

RPID

Rapid Micro Biosystems, Inc.

$2.92

-1.68%

$129.42M

INGN

Inogen, Inc.

$6.20

+1.14%

$168.84M

Frequently Asked Questions

What is Treace Medical Concepts, Inc.'s P/E ratio?

Treace Medical Concepts, Inc. (TMCI) has a trailing twelve-month (TTM) P/E ratio of -1.57. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Treace Medical Concepts, Inc. pay a dividend?

No, Treace Medical Concepts, Inc. (TMCI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Treace Medical Concepts, Inc.'s market cap?

Treace Medical Concepts, Inc. (TMCI) has a market capitalization of $94.30 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.